Electric zaps to the heart: a new hope for stubborn AF?
NCT ID NCT06128174
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a device called the Farawave catheter, which uses electrical pulses to destroy heart tissue causing long-standing atrial fibrillation. Twenty adults with this condition for over a year will undergo the procedure. The goal is to see if it stops abnormal heart rhythms for at least a year.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Farawave PFA catheter (device that uses electrical energy to destroy heart tissue causing abnormal signals)
What this could lead to
If successful, this could offer a new, safer way to control long-standing atrial fibrillation and reduce the need for lifelong medication.
What could go wrong
This is a small pilot study with only 20 participants, so results may not apply to everyone. The procedure carries risks like bleeding, infection, or heart damage.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LONG-STANDING PERSISTENT AF are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mount Sinai Hospital
New York, New York, 10029, United States